Suven Life Sciences Board Meeting on Aug 6 to Approve Un-Audited Financial Results

Suven Life Sciences Limited has announced that its Board of Directors will convene on August 6, 2026. The primary agenda item for this meeting is to consider and approve the Un-Audited Financial Results of the company, both on a standalone and consolidated basis, for the quarter that ended on June 30, 2026. Additionally, the board will discuss related matters. The company has also informed that the trading window for its securities, which was closed from July 1, 2026, will remain shut for 48 hours post the declaration of these financial results, in compliance with the SEBI (LODR) Regulations, 2015 and the company's insider trading code.